Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash Flows from Operating Activities:      
Net loss $ (522) $ (2,382) $ (5,180)
Adjustments to reconcile net loss to net cash used in operating activities:      
Deferred income tax benefit     (6,550)
Depreciation 389 550 495
Amortization of intangible and other assets 5,726 4,318 5,149
Stock-based compensation 2,141 2,719 1,711
Change in fair value of contingent consideration (2,248) 864 1,419
Other noncash items affecting net income 1,349    
Changes in operating assets and liabilities, net of the effect of the acquisition:      
(Increase) decrease in trade receivables, net (11,780) (15,111) (10,291)
(Increase) decrease in unbilled contracts receivable (5,224) (2,246)  
(Increase) decrease in inventories, net (4,430) (7,234) (60)
(Increase) decrease in prepaid and other assets (4,822) (699) (977)
Increase (decrease) in accounts payable and accrued liabilities 13,216 2,532 (19)
Net cash used in operating activities (6,205) (16,689) (14,303)
Cash Flows from Investing Activities:      
Acquisition of business and other, net of cash acquired (11,360) (10,499) (11,521)
Payment of acquisition obligations (1,015)    
Purchase of property and equipment (555) (462) (485)
Net cash used in investing activities (12,930) (10,961) (12,006)
Cash Flows from Financing Activities:      
Proceeds from the issuance of common stock, net of issuance costs and other 16,192 8,960 8,614
Net proceeds from revolving credit facility 3,967 13,266 8,760
Repayments of notes payable and short-term borrowings (360) (390) (1,552)
Proceeds from loans from affiliates of controlling stockholders, net     14,857
Proceeds from the issuance of preferred stock, net of issuance costs     (94)
Net cash provided by financing activities 19,799 21,836 30,585
Net increase (decrease) in cash and cash equivalents 664 (5,814) 4,276
Cash and cash equivalents, beginning of period 219 6,033 1,757
Cash and cash equivalents, end of period 883 219 6,033
Supplemental Disclosure of Cash Flow Information:      
Cash paid during the period for interest 1,837 688 543
Non-Cash Investing and Financing Activities:      
Contingent consideration for acquisitions 4,132 1,550 9,976
Issuance of promissory notes for acquisition 2,000 10,000  
Deferred consideration for acquisition   350  
Exchange of trade accounts payable for note     3,736
Conversion of preferred stock for common stock     36,843
Accrual of dividends on preferred stock     1,449
In-kind dividends on Series C preferred stock     1,000
Common Stock | Contingent Consideration      
Non-Cash Investing and Financing Activities:      
Issuance of stock $ 6,630 6,316  
Common Stock | Value Lighting      
Non-Cash Investing and Financing Activities:      
Issuance of stock   $ 9,702 23,111
Series G Preferred Stock      
Non-Cash Investing and Financing Activities:      
Issuance of stock     $ 18,000